5 things to know about prescribing antipsychotics

New long-acting injectables are worth considering when compliance is an issue

GPs are now responsible for 70% of antipsychotic medication initiations, Australian research shows.
The introduction of long-acting injectables (LAIs) has changed the treatment landscape significantly, according to an international expert in psychiatry.
All doctors with mental health patients need to be across these drugs, says Professor Wolfgang Fleischhacker from Austria’s Medical University of Innsbruck.
Speaking in Sydney recently, Professor Fleischhacker says LAIs are a good option when compliance is an issue but cautions that regular supervision is still necessary.